- Filed
- Jan 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 6, 2025 | 7.21M sh |
| Long Term Debt | Q1 2025 · Nov 30, 2024 | $744K |
| Long Term Debt | Q1 2025 · Aug 31, 2024 | $870K |
| Short Term Debt | Q1 2025 · Nov 30, 2024 | $2.85M |
| Short Term Debt | Q1 2025 · Aug 31, 2024 | $2.85M |
| Stockholders Equity | Q1 2025 · Nov 30, 2024 | $1.58M |
| Stockholders Equity | Q1 2025 · Aug 31, 2024 | $2.2M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $7.11M |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $7.02M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $8.82M |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $8.89M |
| Current Assets | Q1 2025 · Nov 30, 2024 | $5.49M |
| Current Assets | Q1 2025 · Aug 31, 2024 | $5.96M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $10.4M |
| Total Assets | Q1 2025 · Aug 31, 2024 | $11.14M |
| Net Income | Q1 2025 · Nov 30, 2024 | −$547K |
| Net Income | Q1 2025 · Nov 30, 2023 | −$598K |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $1.67M |
| Cash And Equivalents restated | Q1 2025 · Nov 30, 2023 | $2.3M |
| Shares Diluted | Q1 2025 · Nov 30, 2023 | 4.89M sh |
| Capex | Q1 2025 · Nov 30, 2023 | $50K |
| Operating Cash Flow | Q1 2025 · Nov 30, 2023 | −$79K |
| Operating Cash Flow restated | Q1 2025 · Aug 31, 2023 | −$984K |
| Eps Diluted | Q1 2025 · Nov 30, 2023 | −$0.12 |
| Eps Basic | Q1 2025 · Nov 30, 2023 | −$0.12 |
| Sga Expense | Q1 2025 · Nov 30, 2023 | $742K |
| Rd Expense | Q1 2025 · Nov 30, 2023 | $372K |
| Operating Income | Q1 2025 · Nov 30, 2023 | −$819K |
| Operating Income | Q1 2025 · Aug 31, 2023 | −$3.4M |
| Gross Profit | Q1 2025 · Nov 30, 2023 | $245K |
| Cost Of Revenue | Q1 2025 · Nov 30, 2023 | $1.41M |